(Total Views: 259)
Posted On: 02/06/2020 6:52:56 AM
Post# of 36549
What are Generex' priorities? What are we looking forward to?
Dividends-GNBT and NGIO
NGIO Spin-off/Listing on NASDAQ
AE 37 Trial Results
S-1 $40M
GNBT Uplisting
Excellagen sales and revenues
Altucell Acquisition/By Extension Rebirth of Diabetes Franchise/Oralyn
MSO/Unsure of Its Current Stage of Completion
Honestly, I have lost track of where we are in relation to other initiatives. Feel free to add them or insert your own priorities.
No one can say Generex is a one-trick biotech pony, but can all this still be accomplished? So much promise and so much concern. It definitely is not boring.
Dividends-GNBT and NGIO
NGIO Spin-off/Listing on NASDAQ
AE 37 Trial Results
S-1 $40M
GNBT Uplisting
Excellagen sales and revenues
Altucell Acquisition/By Extension Rebirth of Diabetes Franchise/Oralyn
MSO/Unsure of Its Current Stage of Completion
Honestly, I have lost track of where we are in relation to other initiatives. Feel free to add them or insert your own priorities.
No one can say Generex is a one-trick biotech pony, but can all this still be accomplished? So much promise and so much concern. It definitely is not boring.
(2)
(0)Scroll down for more posts ▼
